These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15565298)
21. Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. Lee JH; Agacinski G; Williams JH; Wilcock GK; Esiri MM; Francis PT; Wong PT; Chen CP; Lai MK Neurochem Int; 2010 Dec; 57(8):985-9. PubMed ID: 21034788 [TBL] [Abstract][Full Text] [Related]
22. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models. Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018 [TBL] [Abstract][Full Text] [Related]
23. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture. Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637 [TBL] [Abstract][Full Text] [Related]
24. [Functional relationships between the cerebrum and cerebellum or the cerebral cortex and deep gray matter in normal subjects and patients with Alzheimer's type dementia]. Hanyu H; Arai H; Abe S; Iwamoto T; Takasaki M No To Shinkei; 1991 Aug; 43(8):763-8. PubMed ID: 1931259 [TBL] [Abstract][Full Text] [Related]
25. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742 [TBL] [Abstract][Full Text] [Related]
26. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Ojala J; Alafuzoff I; Herukka SK; van Groen T; Tanila H; Pirttilä T Neurobiol Aging; 2009 Feb; 30(2):198-209. PubMed ID: 17658666 [TBL] [Abstract][Full Text] [Related]
27. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease. Schröder H; Giacobini E; Struble RG; Luiten PG; van der Zee EA; Zilles K; Strosberg AD Brain Res Bull; 1991 Nov; 27(5):631-6. PubMed ID: 1756381 [TBL] [Abstract][Full Text] [Related]
28. Impairment of G(salpha) function in human brain cortex of Alzheimer's disease: comparison with normal aging. Hashimoto E; Ozawa H; Saito T; Gsell W; Takahata N; Riederer P; Frölich L J Neural Transm (Vienna); 2004 Mar; 111(3):311-22. PubMed ID: 14991457 [TBL] [Abstract][Full Text] [Related]
29. Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease. Li C; Wang J; Gui L; Zheng J; Liu C; Du H J Alzheimers Dis; 2011; 27(2):281-90. PubMed ID: 21799248 [TBL] [Abstract][Full Text] [Related]
30. Neuronal apoptosis inhibitory protein (NAIP)-like immunoreactivity in brains of adult patients with Down syndrome. Seidl R; Bajo M; Böhm K; LaCasse EC; MacKenzie AE; Cairns N; Lubec G J Neural Transm Suppl; 1999; 57():283-91. PubMed ID: 10666683 [TBL] [Abstract][Full Text] [Related]
31. Morphometric changes in the cortical microvascular network in Alzheimer's disease. Richard E; van Gool WA; Hoozemans JJ; van Haastert ES; Eikelenboom P; Rozemuller AJ; van de Berg WD J Alzheimers Dis; 2010; 22(3):811-8. PubMed ID: 20858968 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study. Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384 [TBL] [Abstract][Full Text] [Related]
33. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843 [TBL] [Abstract][Full Text] [Related]
35. [Total flavones derived from Lagotis brevituba maxim reduce the levels of inflammatory cytokines in cerebral cortex and hippocampus of Alzheimer's disease mice]. Yang B; Hou Q; Hu F; Zhang F Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):881-5. PubMed ID: 27363265 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J; Rose-John S; Garbers C Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424 [TBL] [Abstract][Full Text] [Related]
37. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters. Muma NA; Mariyappa R; Williams K; Lee JM Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374 [TBL] [Abstract][Full Text] [Related]
38. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. Sherwin JR; Smith SK; Wilson A; Sharkey AM J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539 [TBL] [Abstract][Full Text] [Related]
39. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software]. Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271 [TBL] [Abstract][Full Text] [Related]
40. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]